U.S. Pharmaceuticals & Biotech Upcoming Dividends

Merck

Market Cap: US$287.3b

Operates as a healthcare company worldwide.

Bristol-Myers Squibb

Market Cap: US$122.1b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Zoetis

Market Cap: US$50.6b

Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

Amgen

Market Cap: US$203.6b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Gilead Sciences

Market Cap: US$181.2b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

AbbVie

Market Cap: US$402.6b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Phibro Animal Health

Market Cap: US$2.0b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

Agilent Technologies

Market Cap: US$32.6b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Perrigo

Market Cap: US$1.4b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.